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Abstract
His-Phe-Tyr-Leu-Pro-Met (HFYLPM) is a synthetic
peptide that stimulates Jurkat T cells resulting in
intracellular calcium ([Ca2+]i) increase in a pertussis
toxin (PTX)-sensitive manner. We have examined the
physiological role of the peptide in T cell activity by
comparative investigation of intracellular signaling
pathways accompanied with HFYLPM-induced T cell
chemotaxis with a well-known chemokine, stromal
cell-derived factor-1 (SDF-1)-induced signalings. Wort-
mannin and genistein inhibited both of HFYLPM-
and SDF-1-induced Jurkat T cell chemotaxis indicat-
ing that phosphoinositide-3-kinase and tyrosine kinase
activity were required for the processes. However,
U-73122 and BAPTA/AM preferentially blocked HFYLPM-
but not SDF-1-induced T cell chemotaxis. It indicates
that phospholipase C/calcium signaling is neces-
sary for only chemotaxis by HFYLPM. One of the
well-known cellular molecules involving chemotaxis,
extracellular signal-regulated protein kinase (ERK),
was activated by SDF-1 but not by HFYLPM ruling
out a possible role of ERK on the peptide-mediated
chemotaxis. These results indicate that the syn-
thetic peptide, HFYLPM, stimulates T cell chemot-
axis showing unique signaling and provide a useful
tool for the study of T cell activation mechanism.
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Introduction
T cells have a central role in the regulation of immune
responses in host immunity (Goetzl et al. 1992; Lee et al.
1999). For the proper role, T cell activity can be modulated
by various extracellular stimuli such as processed pep-
tides on major histocompatibility complex molecules of
antigen-presenting cells (Zoller 1988; Ha-Lee et al. 2000).
Among these extracellular stimuli, chemoattractants including
several chemokines that regulate T cell functions have
been receiving attention for a long time. Most of T cell
chemoattractants stimulate the cells via activation of
pertussis toxin (PTX)-sensitive G-protein-coupled receptor
(GPCR) (Tenscher et al. 1996). Binding of chemoattrac-
tants to their specific receptors induce intracellular
calcium ([Ca2+]i) increase, cytoskeletal rearrangement,
receptor induction, and the production of bioactive lipids
(Castro et al. 1996; Kowalska et al. 2000; Wang et al.
2000; Ragno et al. 2001). On the critical role of chemo-
attractants in T cell function, each chemoattractant
modulates chemotactic migration of the cells (Gillitzer
2001). While understanding of the biological role of
chemoattractants has increased substantially in recent
years, relatively little is known about the signaling
pathways that mediate chemotactic migration of T cells.
Keeping in mind the important role of chemoattractants
for T cell function, the identification of new chemo-
attractants and the characterization of their action
mechanism are essentially needed.
We previously isolated a peptide, His-Phe-Tyr-Leu-
Pro-Met-CONH2 (HFYLPM), from a peptide library and
identified as a synthetic peptide that could stimulate
superoxide generation in human monocytes (Bae et al.
2001). The peptide induced the intracellular calcium
mobilization via activation of phosphoinositide-specific
phospholipase C (PLC) in monocytes (Bae et al. 2001).
It also exhibits cell type specificity affecting in several
hematopoietic cells including Jurkat T cells (Bae et al.
2001). The peptide does not have any effect on non-
hematopoietic cells such as fibroblasts and neuronal
cells (Bae et al. 2001). However, the physiological role
of HFYLPM on T cell activity is not examined until now.
Since the peptide induced chemotactic migration of
monocytes, in this study we investigated a possible role
of HFYLPM as a T cell chemoattractant. We also
examined the signaling pathway of the peptide leading
to chemotaxis of Jurkat T cells.
Materials and Methods
Materials
The peptide was synthesized, purified, and prepared in
the Peptide Library Support Facility at Pohang University of
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Science and Technology as described previously (Beak
et al. 1996; Seo et al. 1997). RPMI 1640 was purchased
from Life Technologies (Grand Island, NY). Dialyzed
fetal bovine serum and supplemented bovine calf serum
were purchased from HyClone (Logan, UT). Fura-2/penta-
acetoxymethyl ester (fura-2/AM) and 1,2bis(2-aminophenoxy)
ethane-N,N,N,N-tetraacetoxymethyl ester (BAPTA/AM) were
purchased from Molecular Probes (Eugene, OR). Myo-
[2-3H]inositol and the ECL kit were purchased from
Amersham Corp. (Bucks, UK). Cell Titer 96 AQueous solution
was purchased from Promega (Southampton, UK).
Cell culture
The Jurkat T lymphoma cells were maintained in RPMI
1640 medium supplemented with 10% fetal bovine serum.
Cells were maintained at densities of 2×105 cells/ml at
37oC in a humidified incubator supplied with 95% air
and 5% CO2.
Chemotaxis assay
Chemotaxis assays were performed using multiwell chambers
(Neuroprobe Inc. Gaithersburg, MD). Briefly, Jurkat T
cells were suspended in RPMI at densities of 3×106
cells/ml, and 1.5×105 of cells were placed onto the
upper well of chamber that is separated by 10 µm pore
polyhydrocarbon filter from peptide, or SDF-1 containing
lower well. After incubation for 3 h at 37oC, non-
migrated cells were discarded, and cells that migrated
across the filter were centrifuged and resuspended in
100 µl of RPMI, then added 20 µl of Cell Titer 96 AQueous
solution. After 2 h, quantification was performed by
checking absorbance at 490 nm.
Measurement of [Ca2+]i
The level of [Ca2+]i was determined by Grynkiewiczs method
using fura-2/AM (Grynkiewicz et al. 1985). Briefly, Cells
were incubated with 3 µM of fura-2/AM at 37oC for 50
min in fresh serum free RPMI 1640 medium under
continuous stirring. Cells were resuspended with serum
free medium and 2×106 cells were aliquoted for each
assay in calcium free Lockes solution (154 mM NaCl,
5.6 mM KCl, 1.2 mM MgCl2, 5 mM HEPES, pH 7.3, 10 mM
glucose, and 0.2 mM EGTA). The fluorescence changes
at the dual excitation wavelength of 340 nm and 380 nm
and the emission wavelength of 500 nm were measured.
Measurement of tyrosine phosphorylation and ERK
activation
Jurkat T cells were resuspended to 1×107 cells/ml in
serum-free RPMI 1640 and then stimulated for various
length of time with 10 µM peptide at 37oC. The reaction
was stopped by discarding the reaction medium and
adding 200 µl of lysis buffer (20 mM Hepes, pH 7.2, 10%
glycerol, 150 mM NaCl, 1% Triton X-100, 50 mM NaF, 1 mM
Na3VO4, 10 µg/ml of leupeptin, and 1mM phenylmethylsulfunyl
fluoride). Proteins were extracted by setting the samples
on ice for 60 min. The extracted proteins were harvest-
ed by centrifugation (15,000 g, 15 min, 4oC) and used
for immunoblot analysis.
Immunoblot analysis
Prepared samples were separated on 8% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and transferred onto nitrocellulose membrane. After
blocking the membrane with 5% skimmed milk in TBST
(10 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 0.05%
Tween 20), the membranes were incubated for 4 h with
1 µg/ml of anti-phosphotyrosine antibodies, antiphospho-
ERK antibodies, or anti-ERK antibodies. Detection was
performed with a peroxidase-conjugated anti-mouse (or
rabbit or goat) IgG secondary antibody and an enhanc-
ed chemiluminescence system (Amersham, UK).
Results
HFYLPM stimulates [Ca2+]i increase in a PTX sensitive
manner in Jurkat T cells
When stimulated with various concentrations of HFYLPM,
Jurkat T cells responded with a concentration-depen-
dent increase of intracellular calcium (Figure 1A). The
peptide evoked a rise in the [Ca2+]i at micromolar con-
centrations, and the maximal response was observed
around 20 µM peptide concentration. As a negative
control we checked the effect of a scrambled sequence
peptide, LFMYHP, for the active peptide on [Ca2+]i
increase in Jurkat T cells, and confirmed that the scram-
bled sequence peptide could not induce any significant
intracellular calcium increase at concentrations up to
20 µM (Figure 1A). To address the effect of PTX-sensi-
tive G-protein for the HFYLPM-induced [Ca2+]i increase,
we introduced PTX. Pretreatment of the Jurkat T cells with
100 ng/ml of PTX for 24 h, almost completely blocked
the peptide-induced [Ca2+]i increase (Figure 1B). The
result indicates that the synthetic peptide, HFYLPM,
stimulates Jurkat T cells leading to [Ca2+]i increase, and
PTX-sensitive G-protein is involved in the process.
HFYLPM induces T cell chemotaxis in a PTX-sensitive
manner
Our previous report (Bae et al. 2001) demonstrating that
HFYLPM acts as a chemoattractant for human monocytes
led us to investigate a possible role of the peptide as a
T cell chemoattractant. To assess the effect of HFYLPM
on T cell migration, chemotaxis assays were performed
in Jurkat T cells by using a modified Boyden chamber
analysis described before (Zhou et al. 1995). The
peptide induced chemotactic migration of Jurkat T cell
within 10 nM-10 µM showing a bell shaped concentration-
responsive curve (Figure 2A). The scrambled sequence
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peptide (LFMYHP) for HFYLPM did not affect on Jurkat
T cell migration within 1 nM-10 µM concentration (Figure
2A). A well-known chemoattractant for Jurkat T cells, stromal
cell-derived factor-1 (SDF-1) also induced chemotactic
migration in the cells (Figure 2A). The chemotactic
activity mediated by peptide at a concentration of 1 µM
is about 60% of that mediated by SDF-1 at a concent-
ration of 10 nM in Jurkat T cells. Recently, it has been
reported that chemokine receptors are coupled to the
PTX-sensitive heterotrimeric G proteins (Tenscher et al.
1996). We checked the effect of PTX on HFYLPM-induced
chemotaxis in Jurkat T cells. As shown in Figure 2B,
HFYLPM-induced chemtaxis was almost completely inhi-
bited by pretreatment of PTX. In the case of SDF-1, PTX
pretreatment also caused almost complete inhibition of
the chemotactic migration (Figure 2B). The result impli-
cates that HFYLPM-induced chemotaxis has signaling
pathways that start from PTX-sensitive G protein-
coupled receptor, as SDF-1-induced one.
PLC-mediated calcium increase is required for
HFYLPM-induced chemotaxis
Generally, chemoattractants have been reported to
induce PI hydrolysis resulting from PLC activation in
leukocytes (Wu et al. 1993). We also observed that
HFYLPM stimulated [Ca2+]i increase in Jurkat T cells
(Figure 1A). The peptide-induced [Ca2+]i increase was
sensitive to the pretreatment of the cells with U-73122,
a specific PLC inhibitor (data not shown), indicating that
HFYLPM-induced [Ca2+]i increase was derived from
PLC activation. The role of PLC activity in HFYLPM-
induced chemotaxis was also examined by using a
specific PLC inhibitor, U-73122. As shown in Figure 3A,
HFYLPM-induced chemotaxis was partially (30% of total)
blocked by U-73122 but not by U-73343, an inactive
analogue for U-73122. SDF-1-induced chemotaxis, how-
ever, was not affected by U-73122 pretreatment (Figure
3A). We also checked the role of intracellular calcium
increase on HFYLPM-induced chemotaxis by using an
intracellular calcium chelator, BAPTA/AM. Pretreatment
of the cells with 1 µg/ml of BAPTA/AM for 30 min prior
to the chemotaxis assay attenuated HFYLPM-induced
chemotaxis without affecting on SDF-1-induced one (Figure
Figure 1. HFYLPM stimulates [Ca2+]i increase of Jurkat T cell in a PTX-
sensitive manner. [Ca2+]i was determined fluorometrically using fura-2/AM,
as described in Materials and Methods. Fura-2 loaded cells were challenged
with various concentrations of HFYLPM or LFMYHP (A). To check the effect
of PTX, cells were incubated in the absence or presence of 100 ng/ml of
PTX for 24 h prior to [Ca2+]i determination. Data are presented as mean
±SE from three independent experiments performed in duplicate.
Figure 2. HFYLPM induces chemotaxis of Jurkat T cell. Assays were
performed using Boyden chamber. Cells (3x106 cells/ml of serum-free RPMI)
were added to the upper wells of a 96-well chemotaxis chamber and
migration across the polycarbonate membrane with 10 µm pore size was
assessed after 3 h-incubation at 37oC. Various concentrations of HFYLPM,
LFMYHP, or 10 nM SDF-1 were used (A). To check the effect of PTX on the
peptide-induced chemotaxis, cells were pretreated with 100 ng/ml of PTX for
24 h prior to the assay (B). The migrated cells were determined by using
One-solution cell titer kit. Data are presented as mean ±SE of three
independent experiments each performed in duplicate.
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3B). These results indicate that HFYLPM- but not SDF-
1-induced chemotaxis requires PLC and calcium signaling.
HFYLPM-induced chemotaxis is phosphatidylinositol-
3-kinase-dependent
It has been reported that phosphatidylinositol 3-kinase
(PI3K) takes major role in leukocytic chemotaxis
(Stoyaniv et al. 1995; Stephen et al. 1997). Recently, it
has been also demonstrated that PI3K is important in T
cell chemotaxis, by several chemoattractants including
SDF-1 (Sotsios et al. 1999). In this study, we checked
whether HFYLPM-induced chemotaxis is PI3K depen-
dent or not by using a PI3K inhibitor, wortmannin. As
shown in Figure 4, pretreatment of Jurkat T cells with
wortmannin caused around 40% of inhibition in both of
HFYLPM- and SDF-1-induced chemotaxis. This result
indicates that PI3K is an important mediator for both
HFYLPM and SDF-1-induced T cell chemotaxis.
HFYLPM-induced chemotaxis is tyrosine kinase activity-
dependent
Since many chemokines stimulate tyrosine kinase acti-
vity in T cells (Entschladen et al. 2000), we also
checked the effect of HFYLPM on tyrosine phosphory-
lation of cellular proteins. As shown in Figure 5A,
HFYLPM enhanced tyrosine phosphorylation levels of
several cellular proteins such as 120 kD, 85 kD, and
60 kD proteins. SDF-1 also caused tyrosine phosphory-
lation of several cellular proteins showing similar pattern
with that of HFYLPM-induced (Figure 5A). Tyrosine
phosphorylation events induced by HFYLPM or SDF-1
were abolished by pretreatment of the cells with a
tyrosine kinase inhibitor, genistein (data not shown). It
was reported that SDF-1-induced T cell chemotaxis was
tyrosine kinase activity-dependent (Entschladen et al.
2000). We checked the role of tyrosine kinase activity
on HFYLPM-induced chemotaxis using genistein. As
shown in Figure 5B, pretreatment of Jurkat T cells with
100 µM of genistein caused around 60% of inhibition of
HFYLPM-induced chemotaxis. SDF-1-induced chemotaxis
was also sensitive to the genistein (Figure 5B). These
results indicate that both HFYLPM- and SDF-1-induced
chemotaxis are tyosine kinase activity-dependent.
SDF-1 but not HFYLPM stimulates ERK activity
Many reports showed that chemoattractants stimulate
ERK activity and this activity is required for the leuko-
cyte chemotaxis event (Dutt et al. 1998; Sotsios et al.
1999). We checked the effect of HFYLPM on ERK acti-
vity by monitoring phosphorylation level of ERK with anti-
phospho-specific ERK antibody. Stimulation of Jurkat T
cells with 10 nM SDF-1 caused time-dependent ERK
activation within 0.5-10 min after treatment (Figure 6).
However, 10 µM HFYLPM could not stimulate ERK acti-
vity in Jurkat T cells (Figure 6). The result suggests that
two different chemoattractants, SDF-1 and HFYLPM,
mediate different signaling in view of ERK activation in
Jurkat T cells.
Discussion
In this study, we demonstrated that the synthetic pep-
Figure 3. HFYLPM-induced T cell chemotaxis is PLC/calcium signaling-
dependent. Jurkat T cells were treated with 2 µM of U-73122, 2 µM of U-
73343 (A) or 1 µg/ml of BAPTA/AM (B) for 15 min or 30 min, respectively.
Then the cells were used for chemotaxis assay with 1 µM HFYLPM or 10 nM
SDF-1 for 3 h. Data are presented as mean±SE from three independent
experiments performed in duplicate.
Figure 4. HFYLPM-induced chemotaxis requires PI3K activity. Cells were
treated with wortmannin (50 µg/ml) or vehicle alone for 15 min. The cells
were used for chemotaxis assay with 1 µM HFYLPM or 10 nM SDF-1 for 3 h.
Data are presented as mean±SE from three independent experiments
performed in duplicate.
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tide, HFYLPM, induced Jurkat T cell chemotaxis. We
also compared the signaling of HFYLPM-induced che-
motaxis with that of SDF-1, a well-known chemokine.
HFYLPM-induced chemotaxis has some overlapped
and some distinct signal pathways with SDF-1-induced
one. HFYLPM and SDF-1 share the signaling via PTX-
sensitive G-protein, PI3K, and tyrosine kinase (Figure
2B, 4, and 5B). The peptide has a distinct signaling
pathway for chemotaxis with SDF-1 in PLC-mediated
calcium and ERK-mediated signaling.
Several reports demonstrated that chemoattactants
including SDF-1 induced PLC activation resulting in
[Ca2+]i increase in T cell (Hesselgesser et al. 1998).
However, the role of chemoattractant-induced PLC/
calcium signaling on T cell chemotaxis was not clearly
understood until now. In this study, we observed
HFYLPM stimulated [Ca2+]i increase via PLC activation
(Figure 1A and data not shown). Since HFYLPM-
induced Jurkat cell migration was sensitive to U-73122
and BAPTA/AM (Figure 2A and 2B), PLC activity as well
as [Ca2+]i increase may be important in the peptide-
induced chemotaxis. Unlike to the HFYLPM-induced
chemotaxis, SDF-1-induced T cell chemotaxis was not
sensitive to U-73122 or BAPTA/AM (Figure 2A and 2B).
These results suggest that PLC/calcium signaling might
be involved in T cell chemotaxis showing a ligand-
specific manner.
PI3K and ERK have been reported to act important
roles in the chemoattractant-mediated signalings as
downstream of PTX-sensitive GPCR (Hii et al. 1999;
Bonacchi et al. 2001). The two molecules, PI3K and
ERK have been reported to play a role in chemotaxis of
T cells (Sotsios et al. 1999). In this study we also
observed that PI3K might be involved in the HFYLPM-
and SDF-1-induced T cell chemotaxis (Figure 4). On
ERK activation, we found that SDF-1 promoted ERK
phosphorylation as reported before (Yonezawa et al.
2000). The ERK activity is reported to be involved in
SDF-1-induced T cell chemotaxis (Hii et al. 1999).
However, the synthetic peptide, HFYLPM, could not
stimulate ERK activity in Jurkat T cells (Figure 6).
Reminding that the two agonists, HFYLPM and SDF-1,
induced T cell chemotaxis, it looks like that while both
PI3K and ERK activation are necessary for SDF-1-
mediated chemotaxis, PI3K-dependent but ERK-indepen-
dent mechanism is activated by HFYLPM-induced chemo-
taxis in Jurkat T cell.
Although several chemokines and chemoattractants
have been identified, no short peptides modulating T
cell chemotaxis have been known until now. In this
study, we demonstrated that HFYLPM modulates T cell
activity in terms of chemotaxis and the peptide-induced
T cell signaling has some unique features against well-
known chemokine, SDF-1-induced one. Taken together,
the synthetic peptide, HFYLPM, can serve as a useful
agonist to characterize T cell activation mechanism.
Figure 5. HFYLPM induces tyrosine kinase activity and HFYLPM-induced
chemotaxis is dependent on tyrosine kinase activity. Cells were challenged
with 1 µM HFYLPM or 10 nM SDF-1 for various lengths of period. The
samples were subjected to SDS-PAGE as described under Materials and
Methods. Immunoblot assay was performed by using anti-phosphotyrosine
antibody (A). Cells were treated with 100 µM genistein or vehicle only for 15
min prior to chemotaxis assay with 1 µM HFYLPM or 10 nM SDF-1. Data
are presented as mean ±SE from three independent experiments performed
in duplicate.
Figure 6. SDF-1 but not HFYLPM stimulates ERK activity. Cells were
challenged with 10 µM HFYLPM or 10 nM SDF-1 for various lengths of
period as indicated. The levels of ERK phosphorylation were measured with
immunoblot analysis by using anti-phospho-ERK antibody. To confirm that
same amounts of proteins were used for the experiment, immunoblot
analysis with anti-ERK antibody was performed.
262 Exp. Mol. Med. Vol. 33(4), 257-262, 2001
Acknowledgements
This work was supported in part by grants from the
innovative research project of POSCO, and the National
Research Laboratory administrated by the Ministry of
Science and Technology
References
Bae YS, Bae HJ, Kim Y, Lee TG, Suh PG, Ryu SH. Identification
of novel chemoattractant peptides for human leukocytes.
Blood 2001;97:2854-62
Baek SH, Seo JK, Chae CB, Suh PG, Ryu SH. Identification
of the peptides that stimulate the phosphoinositide hydrolysis
in lymphocyte cell lines from peptide libraries. J Biol Chem
1996;271:8170-75
Bonacchi A, Romagnani P, Romanelli RG, Efsen E, Annunziato F,
Lasagni L, Francalanci M, Serio M, Laffi G, Pinzani M, Gentilini
P, Marra F. Signal transduction by the chemokine receptor
CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol
3-kinase/Akt controls cell migration and proliferation in human
vascular pericytes. J Biol Chem 2001;276:9945-54
Castro M, Bjoraker JA, Rohrbach MS, Limper AH. Candida
albicans induces the release of inflammatory mediators from
human peripheral blood monocytes. Inflammation 1996;20:107-22
Dutt P, Wang JF, Groopman JE. Stromal cell-derived factor-1
alpha and stem cell factor/kit ligand share signaling pathways
in hemopoietic progenitors: a potential mechanism for cooperative
induction of chemotaxis. J Immunol 1998;161:3652-58
Entschladen F, Gunzer M, Scheuffele CM, Niggemann B,
Zanker KS. T lymphocytes and neutrophil granulocytes differ
in regulatory signaling and migratory dynamics with regard to
spontaneous locomotion and chemotaxis. Cell Immunol 2000;
199:104-14
Gillitzer R. Inflammation in human skin: a model to study
chemokine-mediated leukocyte migration in vivo. J Pathol
2001;194:393-94
Goetzl EJ, Sreedharan SP. Mediators of communication and
adaptation in the neuroendocrine and immune systems.
FASEB J 1992;6:2646-52
Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+
indicators with greatly improved fluorescence properties. J Biol
Chem 1985;260:3440-50
Ha-Lee YM, Lee Y, Kim YK, Sohn J. Cross-linking of CD4
induces cytoskeletal association of CD4 and p56lck. Exp Mol
Med 2000;32:18-22
Hesselgesser J, Liang M, Hoxie J, Greenberg M, Brass LF,
Orsini MJ, Taub D, Horuk R. Identification and characterization
of the CXCR4 chemokine receptor in human T cell lines:
ligand binding, biological activity, and HIV-1 infectivity. J
Immunol 1998;160:877-83
Hii CS, Stacey K, Moghaddami N, Murray AW, Ferrante A.
Role of the extracellular signal-regulated protein kinase
cascade in human neutrophil killing of Staphylococcus aureus
and Candida albicans and in migration. Infect Immun
1999;67:1297-302
Kowalska MA, Ratajczak MZ, Majka M, Jin J, Kunapuli S,
Brass L, Poncz M. Stromal cell-derived factor-1 and macrophage-
derived chemokine: 2 chemokines that activate platelets. Blood
2000:96:50-57
Lee WH, Lee Y, Kim JR, Chu JA, Lee SY, Jung JO, Kim JS,
Kim S, Seo JD, Rhee SS, Park JE. Activation of monocytes,
T-lymphocytes and plasma inflammatory markers in angina
patients. Exp Mol Med 1999:31:159-64
Ragno S, Romano M, Howell S, Pappin DJ, Jenner PJ,
Colston MJ. Changes in gene expression in macrophages
infected with Mycobacterium tuberculosis: a combined transcriptomic
and proteomic approach. Immunology 2001;104:99-108
Seo JK, Choi SY, Kim Y, Baek SH, Kim KT, Chae CB,
Lambeth JD, Suh PG, Ryu SH. A peptide with unique receptor
specificity: stimulation of phosphoinositide hydrolysis and
induction of superoxide generation in human neutrophils. J
Immunol 1997;158:1895-901
Sotsios Y, Whittaker GC, Westwick J, Ward SG. The CXC
chemokine stromal cell-derived factor activates a Gi-coupled
phosphoinositide 3-kinase in T lymphocytes. J Immunol 1999;
163:5954-63
Stephens LR, Equinoa A, Erdjument-Bromage H, Lui M,
Cooke F, Coadwell J, Smrcka AS, Thelen M, Cadwallader K,
Tempst P, Hawkins PT. The G beta gamma sensitivity of a
PI3K is dependent upon a tightly associated adaptor, p101.
Cell 1997;89:105-14
Stoyanov B, Volinia S, Hanck T, Rubio I, Loubtchenkov M,
Malek D, Stoyanova S, Vanhaesebroeck B, Dhand R,
Nurnberg B, Gierschik P, Seedorf K, Hsuan JJ, Waterfield MD,
Wetzker R. Cloning and characterization of a G protein-activated
human phosphoinositide-3 kinase. Science 1995;269:690-93
Tenscher K, Metzner B, Schopf E, Norgauer J, Czech W.
Recombinant human eotaxin induces oxygen radical production,
Ca(2+)-mobilization, actin reorganization, and CD11b upregulation
in human eosinophils via a pertussis toxin-sensitive heterotrimeric
guanine nucleotide-binding protein. Blood 1996;88:3195-99
Wang JF, Park IW, Groopman JE. Stromal cell-derived factor-
1alpha stimulates tyrosine phosphorylation of multiple focal
adhesion proteins and induces migration of hematopoietic
progenitor cells: roles of phosphoinositide-3 kinase and
protein kinase C. Blood 2000;95:2505-13
Wu D, LaRosa GJ, Simon MI. G protein-coupled signal
transduction pathways for interleukin-8. Science 1993;261:101-103
Yonezawa A, Hori T, Sakaida H, Uchiyama T. SDF-1 has
costimulatory effects on human T cells: possible involvement of
MAPK (ERK2) activation. Microbiol Immunol 2000;44:135-41
Zhou D, Luini W, Bernasconi S, Diomede I, Salmona M,
Mantovani A, Sozzani S. Phosphatidic acid and lysophosphatidic
acid induce haptotactic migration of human monocytes. J Biol
Chem 1995;270:25549-56
Zoller M. IFN-treatment of B16-F1 versus B16-F10: relative
impact on non-adaptive and T-cell-mediated immune defense
in metastatic spread. Clin Exp Metastasis 1988;6:411-29
